Alterity Therapeutics Ltd
ATH434
Multiple System Atrophy
Countdown
177days
Phase 3 readout · ~ Dec 31, 2026 estimated
What's at stake
Phase 3 trial results for ATH434 in Multiple System Atrophy are due ~ Dec 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 12h ago
“Pivotal Phase 3 trial activities on track to initiate by year-end 2026”